Indian Patent Office rejects TB Alliance patent to facilitate generic competition for WHO regimen
GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims + Mains·
IPR vs Public Health: a GS3 case study on balancing patent rights with affordable access to essential medicines.
Why in news
The Indian Patent Office rejected a patent application by the Global Alliance for TB Drug Development (TB Alliance) to facilitate generic competition for a WHO-recommended TB treatment regimen.
Background
The Indian Patent Office upheld all grounds of opposition against the BPaL combination (bedaquiline, pretomanid, and linezolid). The opposition was filed by multiple entities including Eldred Tellis, Lawyers’ Collective, and Médecins Sans Frontières Access Campaign.
Facts for Prelims
- S&TBPaL combination: A TB drug regimen consisting of bedaquiline, pretomanid, and linezolid.
- BodyTB Alliance: Global Alliance for TB Drug Development.
Prelims practice question
Which drug regimen was the subject of the patent rejection by the Indian Patent Office?
- (a)Z-Pak regimen
- (b)ART drugs
- (c)BPaL combination
- (d)H3N2 vaccine
Show answer
Answer: (c) BPaL combination — The Indian Patent Office upheld opposition against the BPaL combination (bedaquiline, pretomanid, and linezolid).
For Mains
Q. Discuss the significance of India's patent regime in balancing the protection of intellectual property rights with the necessity of ensuring affordable access to essential medicines.
Dimensions to cover in your answer
- Public health priority: Prioritizing generic competition for WHO-recommended regimens over private patent claims
- Legal scrutiny: Role of public interest oppositions in upholding the spirit of the Indian Patents Act
- Market dynamics: Impact of patent rejections on the availability and pricing of life-saving tuberculosis drugs
Keywords: Intellectual Property Rights · Generic Competition · Public Health · Bedaquiline · Patent Opposition · Access to Medicine
More Science & Technology notes
- Telangana Fire Department mandates specific suppression systems and ventilation for data centre NOCs · 29 October 2026
- US Defence Intelligence Agency releases WorldView-3 photo of China's Shenlong space plane · 29 October 2026
- 300,000 people live in high-risk Himalayan zones as built-up land grew 45% · 29 October 2026
- 9.5 severity memory-corruption flaw allows attackers to execute code before Secure Boot loads · 29 October 2026
- Spacecraft with robotic claws to capture two defunct satellites for atmospheric incineration by 2032 · 29 October 2026
- CSIR-NIIST signs MOU with Mridaa Polymers to commercialize bio-polymer bottles from corn and sugarcane · 28 October 2026
Something wrong, or something missing?
Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.